Latest

virology

This shows a woman and child in surgical masks

·March 10, 2020·4 min read

Knowing more about a virus threat may not satisfy you

People who rate themselves as highly knowledgeable about new viral infection threats could also be more likely to believe they don't know enough.

Featured Neuroscience Open Neuroscience Articles

·March 9, 2020·5 min read

5.1 days incubation period for COVID-19

Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.

Featured Neuroscience Neuroscience Videos Open Neuroscience Articles

·March 6, 2020·3 min read

Potential drug to block coronavirus identified

A clinically proven drug known to block an enzyme essential for the viral entry of Coronavirus into the lungs blocks the COVID 19 (SARS-CoV-2) infection. The drug, Camostat mesilate, is a drug approved in Japan to treat pancreatic inflammation. Results suggest this drug may also protect against COVID 19. Researchers call for further clinical trials.

Featured Neuroscience

·February 29, 2020·5 min read

How to Prepare for a Coronavirus Outbreak in the U.S.

Researchers explain how the general public can help protect themselves and those around them from coronavirus.

Featured Neuroscience

·February 29, 2020·9 min read

A big coronavirus mystery: What about the children?

Infectious disease experts report between 40% and 70% of adults could become infected with coronavirus during the outbreak. In a new interview, Dr. Lipsitch, head of Harvard's T.H. Chan School of Public Health's Center for Communicable Disease Dynamics, discusses the risks and spread potential of COVID-19, and addresses how the infection could impact children's' health.

Featured Neurology Neuroscience

·October 21, 2019·8 min read

Polio-like disease AFM linked to enterovirus

Researchers detected immunological remnants of enterovirus in the nervous systems of more than 12 patients with acute flaccid myelitis (AFM). The findings provide the strongest evidence to date that AFM is caused by a virus. The discovery could lead to improved diagnostics for the condition and the development of a vaccine for AFM.

Featured Neurology Neuroscience Open Neuroscience Articles

·July 16, 2019·3 min read

Gut microbes protect against neurologic damage from viral infections

A healthy and diverse microbiome is essential for quickly clearing viral infections in the nervous system to prevent risks associated with multiple sclerosis. Mice with lower gut bacteria had weaker immune responses and were unable to eliminate viruses, leading to worsening paralysis. Those treated with antibiotics before infection had fewer microglia.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles Psychology

·July 11, 2019·4 min read

Are the ‘viral’ agents of MS, ALS and schizophrenia buried in our genome?

Retroviruses may be a missing causal link in diseases like ALS, multiple sclerosis and schizophrenia.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·May 27, 2019·4 min read

Coat of proteins makes viruses more infectious and links them to Alzheimer’s disease

Herpes simplex virus type 1 (HSV-1) and respiratory syncytial virus (RSV) interact with biological fluids, creating a coat of proteins around the viral surface. This results in the viruses becoming more infectious and can contribute to the formation of amyloid plaques. In animal models, researchers found these viruses can bind to amyloid proteins, which aggregate into plaques that contribute to Alzheimer's disease. HSV-1 is able to accelerate the transformation of soluble amyloid proteins into amyloid plaques.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 7, 2019·5 min read

Does herpes cause Alzheimer’s?

The herpes simplex virus 1, the virus responsible for cold sores, may account for 50% of Alzheimer's disease cases. HSV1 causes protein deposits which are characteristic of Alzheimer's disease. Findings also reveal antiviral treatments can help to reduce the risk of developing Alzheimer's in those with HSV1.

Featured Neuroscience Psychology

·January 9, 2019·5 min read

Schizophrenia Linked to Abnormal Immune Response to Herpes Virus that Causes Mono

A new study reports people with schizophrenia have higher levels of antibodies against Epstein-Barr virus, a herpes virus that causes mononucleosis. Researchers propose two explanations for the link to the heightened immune response to the virus: schizophrenia may alter the immune system, making patients more susceptible to EBV, or EBV may increase the risk of developing schizophrenia.